Professor Rodney Hicks
Rod is a Professorial Fellow of the University of Melbourne and Director of the Centre for Molecular Imaging and Therapeutic Nuclear Medicine at the Peter MacCallum Cancer Centree. He has pioneered the use of PET and PET/CT in the assessment of cancer. His group has a strong focus on translational research, genomics of rare cancers, and radiotracer development. He is actively involved in the treatment of neuroendocrine tumours, having first established peptide receptor radionuclide therapy (PRRT) in Australia in 1996. The Neuroendocrine Service, of which he is Co-Chair, was recently certified as a European Neuroendocrine Tumour Society Centre of Excellence. He has published over 450 peer-reviewed articles and holds numerous national and international research grants. He serves as Editor-in-Chief of Cancer Imaging, International Associate Editor of The Journal of Nuclear Medicine and as an Honorary Director of the Unicorn Foundation, which supports patients with neuroendocrine neoplasia. He was inducted as a Fellow of the Australian Academy of Health and Medical Science in 2015.